Drug Interaction Report

Simvastatin and Elexacaftor: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 4, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Simvastatin

Flolipid Flolipid® Zocor Zocor®
+

Elexacaftor

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 4, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 168 documented Simvastatin interactions, 99 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Elexacaftor may raise simvastatin blood levels by slowing its liver transport, which can increase the risk of muscle side effects; keep taking both as prescribed and report any muscle pain to your care team.

What's going on: Simvastatin (Zocor) is cleared by liver transporters that help move it into and out of the liver. Elexacaftor can slow those transporters down. In theory, that could let more simvastatin build up in your blood than usual.

Higher simvastatin levels can raise the small chance of muscle aches or, rarely, more serious muscle problems. The good news is this concern is based on how the drugs work rather than strong real-world reports, and your care team can manage it easily. If you take both, just let your pharmacist or doctor know, and mention any new muscle pain, tenderness, or weakness so they can keep an eye on things and adjust if needed.

Mechanism: Elexacaftor inhibits OATP1B1/OATP1B3-mediated hepatic uptake. Simvastatin (active acid form) is an OATP1B1/1B3 substrate, so inhibition can raise its systemic exposure (AUC/Cmax).

Direction: Increased simvastatin exposure, raising myopathy/rhabdomyolysis risk. Neither is a prodrug in a way that reverses this; the statin acid is the relevant substrate.

  • Evidence: Theoretical (transporter-based prediction).
  • Onset: Unspecified.
  • Management: Use with caution; monitor for muscle symptoms and consider CK if symptomatic. Statin dose may be individualized by the care team; consider closer follow-up.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased OATP1B1/OATP1B3 substrate exposure

Interaction Deep Dive

Taking elexacaftor together with medications that act as substrates for both OATP1B1 and OATP1B3 may raise the plasma levels of those OATP1B1/OATP1B3 substrates. Exercise caution and apply suitable monitoring whenever elexacaftor is given alongside OATP1B1/OATP1B3 substrates1.

Why it happens (mechanism)

Inhibition of OATP1B1-mediated efflux transport by elexacaftor; inhibition of OATP1B3-mediated efflux transport by elexacaftor

How to manage this interaction

Keep taking both as prescribed unless your prescriber tells you otherwise. Here is how a care team typically handles this:

  • Use the combination with caution and monitor more closely for muscle-related effects.
  • The simvastatin dose may need to be adjusted and individualized by your care team.
  • Report any new or unexplained muscle pain, tenderness, weakness, or dark urine promptly.

What to do: Tell your pharmacist and prescriber you take both so they can decide on the right dose and monitoring for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Simvastatin and Elexacaftor together?

Elexacaftor may raise simvastatin blood levels by slowing its liver transport, which can increase the risk of muscle side effects; keep taking both as prescribed and report any muscle pain to your care team. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Simvastatin and Elexacaftor interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Simvastatin and Elexacaftor interaction managed?

Keep taking both as prescribed unless your prescriber tells you otherwise. Here is how a care team typically handles this: Use the combination with caution and monitor more closely for muscle-related effects. The simvastatin dose may need to be adjusted and individualized by your care team. Report any new or unexplained muscle pain, tenderness, weakness, or dark urine promptly. What to do: Tell yo… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Simvastatin or Elexacaftor need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: TRIKAFTA(R) oral tablets oral granules, elexacaftor, tezacaftor, ivacaftor oral tablets oral granules; ivacaftor oral tablets oral granules. Vertex Pharmaceuticals Incorporated (per FDA), Boston, MA, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.